Cargando…

Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer

Prostate cancer is the second most common cancer in men and represents a significant healthcare burden worldwide. Therapeutic options in the metastatic castration-resistant setting remain limited, despite advances in androgen deprivation therapy, precision medicine and targeted therapies. In this re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulvey, Arthur, Muggeo-Bertin, Emilien, Berthold, Dominik R., Herrera, Fernanda G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115849/ https://www.ncbi.nlm.nih.gov/pubmed/35603186 http://dx.doi.org/10.3389/fimmu.2022.859785

Ejemplares similares

Erratum: Overcoming immune resistance with radiation therapy in prostate cancer
Publicado: (2023)

A new method to visualize and to spare the ureters during SBRT for oligo metastatic patients
por: Muggeo-Bertin, Emilien, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy in Patients with Oligometastatic Disease: Clinical State of the Art and Perspectives
por: Kinj, Rémy, et al.
Publicado: (2022)

Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy
por: D’Amico, Silvia, et al.
Publicado: (2022)

Radiation Therapy after Radical Prostatectomy: Implications for Clinicians
por: Herrera, Fernanda G., et al.
Publicado: (2016)

Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer
por: Qi, Xiaowen, et al.
Publicado: (2022)

Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
por: Zhou, Xiaoting, et al.
Publicado: (2022)

Editorial: Overcoming the Immune Microenvironment of Hepatocellular Cancer
por: Shetty, Shishir, et al.
Publicado: (2021)

Overcoming tumor resistance mechanisms in CAR-NK cell therapy
por: Valeri, Antonio, et al.
Publicado: (2022)

Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances
por: Movassaghi, Miyad, et al.
Publicado: (2021)

Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment
por: Darragh, Laurel B., et al.
Publicado: (2019)

Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy
por: Kim, Byeong Mo, et al.
Publicado: (2015)

Overcoming Immunotherapy Resistance With Radiation Therapy and Dual Immune Checkpoint Blockade
por: Davidson, Tara, et al.
Publicado: (2022)

Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
por: Lemos, Henrique, et al.
Publicado: (2020)

Wnt Inhibition Sensitizes PD-L1 Blockade Therapy by Overcoming Bone Marrow-Derived Myofibroblasts-Mediated Immune Resistance in Tumors
por: Huang, Tinglei, et al.
Publicado: (2021)

A versatile toolkit for overcoming AAV immunity
por: Li, Xuefeng, et al.
Publicado: (2022)

Editorial: Overcoming challenges in mucosal immunity: 2022
por: Leceta, Javier, et al.
Publicado: (2023)

Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
por: Hou, Aohan, et al.
Publicado: (2020)

A Century of Radiation Therapy and Adaptive Immunity
por: Schaue, Dörthe
Publicado: (2017)

Overcoming Target Driven Fratricide for T Cell Therapy
por: Breman, Eytan, et al.
Publicado: (2018)

Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies
por: Shi, Tao, et al.
Publicado: (2023)

Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer
por: Lin, Jian-Zhong, et al.
Publicado: (2017)

Targeting Innate Immunity to Enhance the Efficacy of Radiation Therapy
por: Dar, Tahir B., et al.
Publicado: (2019)

Radiation therapy in the era of immune treatment for hepatocellular carcinoma
por: Chen, Lingjuan, et al.
Publicado: (2023)

A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer
por: Sooi, Kenneth, et al.
Publicado: (2023)

Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy
por: Lv, Zixin, et al.
Publicado: (2023)

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
por: De Cicco, Paola, et al.
Publicado: (2020)

Remodeling tumor microenvironment with natural products to overcome drug resistance
por: Zhang, Wanlu, et al.
Publicado: (2022)

IgY antibodies: The promising potential to overcome antibiotic resistance
por: El-Kafrawy, Sherif A., et al.
Publicado: (2023)

Anti-glucocorticoid-induced Tumor Necrosis Factor–Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects
por: Schoenhals, Jonathan E., et al.
Publicado: (2018)

Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance
por: Passarelli, Anna, et al.
Publicado: (2020)

The Tumor Immune Contexture of Prostate Cancer
por: Vitkin, Natasha, et al.
Publicado: (2019)

The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review
por: Ollivier, Luc, et al.
Publicado: (2023)

Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer
por: Bryant, Geoffrey, et al.
Publicado: (2017)

NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy
por: Schmiedel, Dominik, et al.
Publicado: (2018)

Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer
por: Moon, Sue Jin, et al.
Publicado: (2021)

Targeting Notch to overcome radiation resistance
por: Yahyanejad, Sanaz, et al.
Publicado: (2015)

Overcoming Drug Resistance and Treating Advanced Prostate Cancer
por: Semenas, Julius, et al.
Publicado: (2012)

Mechanisms and Approaches for Overcoming Enzalutamide Resistance in Prostate Cancer
por: Vander Ark, Alexandra, et al.
Publicado: (2018)

Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer
por: Wu, Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d7q7dhu21l5uira66rrbdjgaiv